These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32327905)

  • 1. Optimized timing of using infliximab in perianal fistulizing Crohn's disease.
    Sun XL; Chen SY; Tao SS; Qiao LC; Chen HJ; Yang BL
    World J Gastroenterol; 2020 Apr; 26(14):1554-1563. PubMed ID: 32327905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab serum concentrations and disease activity in perianal fistulizing Crohn's disease: a cross-sectional study.
    Miranda EF; Nones RB; Baraúna FB; de Nardi Marçal G; Olandoski M; de Moraes TP; Kotze PG
    Tech Coloproctol; 2024 Jul; 28(1):86. PubMed ID: 39031218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.
    El-Matary W; Walters TD; Huynh HQ; deBruyn J; Mack DR; Jacobson K; Sherlock ME; Church P; Wine E; Carroll MW; Benchimol EI; Lawrence S; Griffiths AM
    Inflamm Bowel Dis; 2019 Jan; 25(1):150-155. PubMed ID: 29912413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
    Papamichael K; Cheifetz AS
    World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease.
    Davidov Y; Ungar B; Bar-Yoseph H; Carter D; Haj-Natour O; Yavzori M; Chowers Y; Eliakim R; Ben-Horin S; Kopylov U
    J Crohns Colitis; 2017 May; 11(5):549-555. PubMed ID: 28453755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
    Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
    Regueiro M; Mardini H
    Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae.
    Maas L; Gao R; Cusumano V; Spartz E; Chowdhury R; Krishna M; Lazarev M; Melia J; Selaru F; Sharma S; Limketkai B; Parian A
    Dig Dis Sci; 2023 Oct; 68(10):3994-4000. PubMed ID: 37540392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice.
    Bourikas LA; Koutroubakis IE
    Curr Drug Targets; 2010 Feb; 11(2):187-97. PubMed ID: 19916954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease.
    Yang BL; Chen YG; Gu YF; Chen HJ; Sun GD; Zhu P; Shao WJ
    World J Gastroenterol; 2015 Feb; 21(8):2475-82. PubMed ID: 25741157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.
    Savoye-Collet C; Savoye G; Koning E; Dacher JN; Lerebours E
    Inflamm Bowel Dis; 2011 Aug; 17(8):1751-8. PubMed ID: 21744430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn's Disease.
    Cao D; Qian K; Zhao Y; Hong J; Chen H; Wang X; Yang N; Zhang C; Cao J; Jia K; Wu G; Zhu M; Shen J; Zhang Y; Cui Z; Wang Z
    J Crohns Colitis; 2023 Apr; 17(4):580-592. PubMed ID: 36322703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease.
    Rasul I; Wilson SR; MacRae H; Irwin S; Greenberg GR
    Am J Gastroenterol; 2004 Jan; 99(1):82-8. PubMed ID: 14687146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
    Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adalimumab induction and maintenance therapy for Crohn's disease. An open-label study].
    López Palacios N; Mendoza JL; Taxonera C; Lana R; Fuentes Ferrer M; Díaz-Rubio M
    Rev Esp Enferm Dig; 2008 Nov; 100(11):676-81. PubMed ID: 19159170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
    Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
    Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.